Editorial |

Primary Percutaneous Coronary Intervention for All?

Christopher P. Cannon, MD
JAMA. 2002;287(15):1987-1989. doi:10.1001/jama.287.15.1987.
Text Size: A A A
Published online


Reperfusion therapy with thrombolysis or primary percutaneous coronary intervention (PCI) has been a major advance in the treatment of acute ST-segment elevation myocardial infarction (MI), with a 25% reduction in mortality with thrombolysis.1 Primary PCI has been considered in the American College of Cardiology/American Heart Association (ACC/AHA) guidelines in 1999 to be an alternative to thrombolysis.2 Since then, the number of trials and number of patients randomized has more than doubled to 21 trials and 6800 patients, all of which show clear benefit of PCI over thrombolysis. A meta-analysis of the randomized trials carried out through 1997 showed a clear reduction in mortality, recurrent MI, stroke, and intracranial hemorrhage. Mortality was reduced a relative 34% (6.5% for thrombolysis vs 4.4% for primary PCI), suggesting that 20 patients' lives would be saved for every 1000 patients treated with primary PCI instead of thrombolytic therapy.3 Nonfatal reinfarction was reduced nearly 50% (5.3% for thrombolysis and 2.9% for PCI) and intracranial hemorrhage was essentially eliminated (1.1% with thrombolysis and 0.1% with PCI).3 In addition, cost appears to be similar between the 2 strategies,4 largely because many patients receive PCI following initial thrombolysis. Thus, based on these initial 10 randomized trials, primary PCI is considered a superior strategy both for efficacy and safety.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 18

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles